Despite the great success of immune checkpoint blockade therapy with PD‐1/PD‐L1 in the treatment of many solid malignancies, a large proportion of HNSCC patients remain unresponsive, including HNSCC.17, 18. Here, CD274 is linked to head and neck squamous cell carcinoma.